Birlaslamc - Health ETF

About Aditya Birla Sun Life Nifty Healthcare ETF

• The Aditya Birla Sun Life Nifty Healthcare ETF is an open-ended, exchange-traded fund offered by the Aditya Birla Sun Life Mutual Fund house.
• The ETF invests in top Nifty healthcare sector companies, capitalising on India's rapid ascent as a thriving global health hub.
• The fund was launched on October 26, 2021.
• Haresh Mehta and Pranav Gupta are the fund managers of Aditya Birla Sun Life Nifty healthcare ETF.
• Aditya Birla Sun Life Nifty Healthcare ETF has assets under management (AUM) that stood at ₹29.73 crore as of June 30, 2024.
• The ETF units are listed on Both Exchange NSE and BSE, one can invest by buying units through their demat account with a registered broker.

Investment Objective & Benchmark

• The investment objective of the scheme is to provide returns, closely corresponding to the total returns of securities as represented by the underlying index.
• The Nifty Healthcare TRI index is the benchmark index for this ETF.
• Stock eligibility in this fund should have a minimum listing history of 1-year and the stock should be available for trading in the F&O segment.
• This scheme invests in the leading companies operating in the healthcare sector and seeks to deliver returns that are commensurate with the performance of Nifty Healthcare TRI.
• The risk factor level of the fund is very high with an expense ratio of 0.22%. Nifty Healthcare ETF is suitable for investors who are seeking long-term capital growth.

Asset Allocation & Portfolio Composition

• The asset allocation of the fund comprises around 99.38% in equities and 0.22% in cash & cash equivalent.
• Aditya Birla Sun Life Nifty Healthcare ETF invests 99.38% of its funds in the healthcare sector.
• The top 10 Holdings in stocks of Aditya Birla Sun Life Nifty healthcare ETF is around 72.92%.

The top 10 company holdings in this ETF include:

• Sun Pharmaceutical Industries Ltd: 21.60%
• Cipla Ltd: 10.41%
• Dr. Reddy Laboratories Ltd: 9.66%
• Apollo Hospitals Enterprise Ltd: 8.05%
• Max Healthcare Institute Ltd: 7.61%
• Divi’s Laboratories Ltd: 7.52%
• Lupin Ltd: 5.24%
• Aurobindo Pharma Ltd: 4.57%
• Zydus Lifesciences Ltd: 3.47%
• Torrent Pharmaceuticals Ltd: 3.38%

The ETF has delivered a return of 43.71% in the last year as of July 22, 2024, compared to the index’s 43.18% return during the period.

Since its inception, the ETF has delivered annualised returns of 16.78%.